The estimated Net Worth of Steve Chaussy is at least $2.54 Milion dollars as of 1 September 2022. Mr. Chaussy owns over 11,425 units of Biosig Technologies Inc stock worth over $471,096 and over the last 9 years he sold BSGM stock worth over $0. In addition, he makes $2,073,250 as Chief Financial Officer at Biosig Technologies Inc.
Sign up
Mr. Chaussy BSGM stock SEC Form 4 insiders trading
Steven has made over 20 trades of the Biosig Technologies Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently he bought 11,425 units of BSGM stock worth $12,910 on 1 September 2022.
The largest trade he's ever made was exercising 12,000 units of Biosig Technologies Inc stock on 16 January 2020 worth over $62,760. On average, Steven trades about 3,105 units every 79 days since 2015. As of 1 September 2022 he still owns at least 1,051,553 units of Biosig Technologies Inc stock.
You can see the complete history of Mr. Chaussy stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Steven Chaussy biography
Steven Chaussy CPA serves as Chief Financial Officer of the Company. Mr. Chaussy has served as our chief financial officer on a full-time basis since January 2018. Mr. Chaussy served as our chief financial officer on a part time basis from May 2011 to January 2018. Mr. Chaussy has been serving as ViralClear’s chief financial officer, secretary and treasurer since November 2018. Since 2005, Mr. Chaussy has been the sole proprietor of Anna & Co., Inc., a consulting company that offers services to small publicly traded companies. Anna & Co., Inc. provides general financial and accounting services, with a special emphasis towards SEC reporting and compliance, to companies that lack sufficient resources to hire full-time employees to provide such services. From 2001 to 2005, Mr. Chaussy provided services as both a chief financial officer and as a consultant to small publicly traded companies. Prior to 2001, Mr. Chaussy served as chief financial officer for a large private distribution and wholesaling company, where he gained international experience. Mr. Chaussy is a graduate of Virginia Polytechnic Institute and State University and is a licensed certified public accountant in Virginia, California and Florida.
What is the salary of Steven Chaussy?
As the Chief Financial Officer of Biosig Technologies Inc, the total compensation of Steven Chaussy at Biosig Technologies Inc is $2,073,250. There are 1 executives at Biosig Technologies Inc getting paid more, with Kenneth Londoner having the highest compensation of $5,034,850.
How old is Steven Chaussy?
Steven Chaussy is 66, he's been the Chief Financial Officer of Biosig Technologies Inc since 2018. There are 3 older and 9 younger executives at Biosig Technologies Inc. The oldest executive at Biosig Technologies Inc is Dr. Budimir S. Drakulic Ph.D., 71, who is the Chief Scientist.
What's Steven Chaussy's mailing address?
Steve's mailing address filed with the SEC is C/O BIOSIG TECHNOLOGIES, INC., 55 GREENS FARMS ROAD, WESTPORT, CT, 06880.
Insiders trading at Biosig Technologies Inc
Over the last 9 years, insiders at Biosig Technologies Inc have traded over $1,778,587 worth of Biosig Technologies Inc stock and bought 1,345,515 units worth $2,296,289 . The most active insiders traders include Kenneth L Londoner, Asher Holzer oraz Jerome B Zeldis. On average, Biosig Technologies Inc executives and independent directors trade stock every 24 days with the average trade being worth of $11,433. The most recent stock trade was executed by Kenneth L Londoner on 13 June 2023, trading 15,600 units of BSGM stock currently worth $19,344.
What does Biosig Technologies Inc do?
biosig technologies, inc. (otcqb: bsgm) is a medical device company that is developing a proprietary technology platform designed to greatly improve the $3 billion electrophysiology (ep) marketplace. led by a proven management team and a veteran, independent board of directors, minneapolis-based biosig is preparing to commercialize its pure ep system.
What does Biosig Technologies Inc's logo look like?
Complete history of Mr. Chaussy stock trades at Biosig Technologies Inc
Biosig Technologies Inc executives and stock owners
Biosig Technologies Inc executives and other stock owners filed with the SEC include:
-
Kenneth Londoner,
Executive Chairman of the Board, Chief Executive Officer -
Steven Chaussy,
Chief Financial Officer -
Kenneth L. Londoner M.B.A., MBA,
Founder, CEO & Exec. Chairman -
Samuel Navarro,
Independent Director -
Jeffrey O'Donnell,
Lead Independent Director -
Martha Pease,
Independent Director -
Andrew Filler,
Independent Director -
David Weild,
Independent Director -
Patrick Gallagher,
Independent Director -
Donald Foley,
Independent Director -
Anthony Zook,
Director -
Manasi Patwardhan,
Director of Strategic Planning -
Olivier Chaudoir,
Senior Director of Marketing -
Julie Stephenson,
Vice President - Clinical Affairs, Senior Director of Clinical Affairs -
Andrew Ballou,
Vice President - Investor Relations -
John Kowalski,
Vice President - Sales -
John Sieckhaus,
Chief Operating Officer -
Gray Fleming,
Chief Commercial Officer -
Steven Chaussy,
Chief Financial Officer -
Natasha Drapeau,
Exec. VP -
Brenda Castrodad,
Director of HR -
Lora Mikolaitis,
VP of Admin. -
Dr. Budimir S. Drakulic Ph.D.,
Chief Scientist -
Steven Eric Abelman,
Director -
Steve Chaussy,
Chief Financial Officer -
Roy T Tanaka,
Director -
Lora Mikolaitis,
10% owner -
Seth H. Z. Fischer,
Director -
Joseph Rafferty,
Chief Commercialization Offcr -
Jerome B Zeldis,
Director -
Asher Holzer,
Director -
Gregory D Cash,
President and CEO -
James L Klein,
Director -
James J Barry,
Director -
John Sieckhaus,
Chief Operating Officer -
Gray Fleming,
Chief Commercial Officer -
Steven J Buhaly,
Chief Financial Officer -
Frederick Hrkac,
Director -
Donald Browne,
Director -
Christopher Allen Baer,
Director